Your browser doesn't support javascript.
loading
Multidisciplinary neurofibromatosis conference in the management of patients with neurofibromatosis type 1 and schwannomatosis in a single tertiary care institution.
Debs, Patrick; Belzberg, Allan; Blakeley, Jaishri; Fayad, Laura; Langmead, Shannon; Little, Emily; Romo, Carlos; Schatz, Krista; Slobogean, Bronwyn; Ahlawat, Shivani.
  • Debs P; The Russell H. Morgan Department of Radiology & Radiological Science, Johns Hopkins University School of Medicine, 601 North Caroline Street, JHOC 3014, Baltimore, MD, 21287, USA.
  • Belzberg A; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Blakeley J; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Fayad L; The Russell H. Morgan Department of Radiology & Radiological Science, Johns Hopkins University School of Medicine, 601 North Caroline Street, JHOC 3014, Baltimore, MD, 21287, USA.
  • Langmead S; Division of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Little E; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Romo C; Comprehensive Neurofibromatosis Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Schatz K; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Slobogean B; McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Ahlawat S; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Skeletal Radiol ; 53(5): 909-916, 2024 May.
Article en En | MEDLINE | ID: mdl-37950060
ABSTRACT

OBJECTIVE:

To evaluate the role of weekly neurofibromatosis (NF) multi-disciplinary conferences (MDC) on the diagnostic and therapeutic plan for patients with NF type 1 (NF1) and schwannomatosis (SWN). MATERIALS AND

METHODS:

This retrospective study reviewed patients with confirmed or suspected NF1 and SWN discussed in weekly MDC from March to July 2021. Demographic data collected included patient age, sex, pre-conference and post-conference diagnosis, radiological studies reviewed, and provider specialties in attendance. Outcomes reported included changes in imaging interpretation and treatment plans, changes in post-conference diagnosis relative to pre-conference diagnosis, and time to completion of the recommended change in treatment.

RESULTS:

Data from 17 MDC "pre-conference" lists included 75 patients (38 female, 37 males, mean age (years) 38 (range 6-80)) with NF1 (52%, 39/75) and SWN (36%, 27/75) discussed over a total of 91 case reviews. 18.7% (14/75) of all patients had NF2-related SWN, and 17.3% (13/75) of all patients had non-NF2 SWN. The MDC led to changes in imaging interpretation in 18.7% and changes in patient management in 74.7% (diagnostic testing (n = 52), surgical plan (n = 24), medical treatment (n = 9), clinical trial status (n = 4), and radiation treatment (n = 1)) of cases. Among patients for whom a change in management was recorded, 91% (62/68) completed at least one recommendation (mean time to completion (days) 41.4 (range 0-278)).

CONCLUSION:

Weekly MDC changes the diagnostic and therapeutic management of the majority of patients discussed (74.7%) and promotes a high adherence rate to recommendations (91%).
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Neurofibromatosis 2 / Neurofibromatosis 1 / Neurofibromatosis / Neurilemoma Límite: Female / Humans / Male Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Neurofibromatosis 2 / Neurofibromatosis 1 / Neurofibromatosis / Neurilemoma Límite: Female / Humans / Male Idioma: En Año: 2024 Tipo del documento: Article